OBJECTIVES: In this study, we evaluated the internal validity of EPICON, an application for grouping ICPC-coded diagnoses from electronic medical records into episodes of care. These episodes are used to estimate morbidity rates in general practice. METHODS: Morbidity rates based on EPICON were compared to a gold standard; i.e. the rates from the second Dutch National Survey of General Practice. We calculated the deviation from the gold standard for 677 prevalence and 681 incidence rates, based on the full dataset. Additionally, we examined the effect of case-based reasoning within EPICON using a comparison to a simple, not case-based method (EPI-0). Finally, we used a split sample procedure to evaluate the performance of EPICON. RESULTS: Morbidity rates that are based on EPICON deviate only slightly from the gold standard and show no systematic bias. The effect of case-based reasoning within EPICON is evident. The addition of case-based reasoning to the grouping system reduced both systematic and random error. Although the morbidity rates that are based on the split sample procedure show no systematic bias, they do deviate more from the gold standard than morbidity rates for the full dataset. CONCLUSIONS: Results from this study indicate that the internal validity of EPICON is adequate. Assuming that the standard is gold, EPICON provides valid outcomes for this study population. EPICON seems useful for registries in general practice for the purpose of estimating morbidity rates.
OBJECTIVES: In this study, we evaluated the internal validity of EPICON, an application for grouping ICPC-coded diagnoses from electronic medical records into episodes of care. These episodes are used to estimate morbidity rates in general practice. METHODS: Morbidity rates based on EPICON were compared to a gold standard; i.e. the rates from the second Dutch National Survey of General Practice. We calculated the deviation from the gold standard for 677 prevalence and 681 incidence rates, based on the full dataset. Additionally, we examined the effect of case-based reasoning within EPICON using a comparison to a simple, not case-based method (EPI-0). Finally, we used a split sample procedure to evaluate the performance of EPICON. RESULTS: Morbidity rates that are based on EPICON deviate only slightly from the gold standard and show no systematic bias. The effect of case-based reasoning within EPICON is evident. The addition of case-based reasoning to the grouping system reduced both systematic and random error. Although the morbidity rates that are based on the split sample procedure show no systematic bias, they do deviate more from the gold standard than morbidity rates for the full dataset. CONCLUSIONS: Results from this study indicate that the internal validity of EPICON is adequate. Assuming that the standard is gold, EPICON provides valid outcomes for this study population. EPICON seems useful for registries in general practice for the purpose of estimating morbidity rates.
Authors: Marion C J Biermans; Ellen H M Theuns-Lamers; Peter Spreeuwenberg; Robert A Verheij; Johannes C van der Wouden; Pieter F de Vries Robbé; Gerhard A Zielhuis Journal: Br J Gen Pract Date: 2009-12 Impact factor: 5.386
Authors: Marion C J Biermans; Geert H Elbers; Robert A Verheij; Willem Jan van der Veen; Gerhard A Zielhuis; Pieter F de Vries Robbé Journal: J Am Med Inform Assoc Date: 2008-08-28 Impact factor: 4.497
Authors: Sandra H van Oostrom; H Susan J Picavet; Boukje M van Gelder; Lidwien C Lemmens; Nancy Hoeymans; Christel E van Dijk; Robert A Verheij; François G Schellevis; Caroline A Baan Journal: BMC Public Health Date: 2012-08-30 Impact factor: 3.295
Authors: Christel E van Dijk; Robert A Verheij; Peter Spreeuwenberg; Peter P Groenewegen; Dinny H de Bakker Journal: BMC Health Serv Res Date: 2011-01-04 Impact factor: 2.655
Authors: Sandra H van Oostrom; Ronald Gijsen; Irina Stirbu; Joke C Korevaar; Francois G Schellevis; H Susan J Picavet; Nancy Hoeymans Journal: PLoS One Date: 2016-08-02 Impact factor: 3.240
Authors: Hendrike C Boshuizen; Marinus J J C Poos; Marjan van den Akker; Kees van Boven; Joke C Korevaar; Margot W M de Waal; Marion C J Biermans; Nancy Hoeymans Journal: Popul Health Metr Date: 2017-04-05
Authors: Yvette M Weesie; Karin Hek; Tjard R J Schermer; Francois G Schellevis; Hubertus G M Leufkens; Elisabeth J Rook; Liset van Dijk Journal: Front Pharmacol Date: 2020-05-14 Impact factor: 5.810
Authors: Inge Spronk; Joke C Korevaar; René Poos; Rodrigo Davids; Henk Hilderink; François G Schellevis; Robert A Verheij; Mark M J Nielen Journal: BMC Public Health Date: 2019-05-06 Impact factor: 3.295
Authors: Sandra H van Oostrom; H Susan J Picavet; Simone R de Bruin; Irina Stirbu; Joke C Korevaar; Francois G Schellevis; Caroline A Baan Journal: BMC Fam Pract Date: 2014-04-07 Impact factor: 2.497